IV drug trial aims to shield ICU Patients' stomachs
NCT ID NCT07399054
Summary
This study will test if giving an intravenous (IV) stomach acid medicine called esomeprazole can help prevent stomach ulcers and acid reflux in patients who are in the intensive care unit (ICU) after surgery. It will involve 50 adult patients to see how well the drug controls stomach acid levels over 72 hours and to check its safety. The goal is to find a better way to protect these vulnerable patients from a common ICU complication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STRESS ULCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.